These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28439934)

  • 1. An International Prophylaxis Study Group (IPSG) survey of prophylaxis in inhibitor positive children/adults with severe haemophilia.
    Carcao MD; Avila L; Leissinger C; Blanchette VS; Aledort L;
    Haemophilia; 2017 Sep; 23(5):e444-e447. PubMed ID: 28439934
    [No Abstract]   [Full Text] [Related]  

  • 2. An International Prophylaxis Study Group (IPSG) survey of prophylaxis in adults with severe haemophilia.
    Carcao MD; Avila L; Leissinger C; Blanchette VS; Aledort L
    Haemophilia; 2017 Sep; 23(5):e447-e450. PubMed ID: 28429874
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of prophylaxis in 2663 children and adults with haemophilia: results of the 2006 Canadian national haemophilia prophylaxis survey.
    Biss TT; Chan AK; Blanchette VS; Iwenofu LN; McLimont M; Carcao MD; ;
    Haemophilia; 2008 Sep; 14(5):923-30. PubMed ID: 18637844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The current status of prophylactic replacement therapy in children and adults with haemophilia.
    Ljung R; Gretenkort Andersson N
    Br J Haematol; 2015 Jun; 169(6):777-86. PubMed ID: 25819695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FEIBA prophylaxis in haemophilia patients: a clinical update and treatment recommendations.
    Perry D; Berntorp E; Tait C; Dolan G; Holme PA; Laffan M; Lassila R; Mumford A; Pasi J; Wilde J; Will A; Yee TT
    Haemophilia; 2010 Jan; 16(1):80-9. PubMed ID: 19780845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful prophylaxis using activated prothrombin complex concentrates (aPCC) in a severe haemophilia A patient with inhibitor previously unresponsive to on-demand daily infusions of aPCC.
    Furukawa S; Nogami K; Ogiwara K; Yada K; Shima M
    Haemophilia; 2017 Sep; 23(5):e481-e484. PubMed ID: 28771891
    [No Abstract]   [Full Text] [Related]  

  • 7. A history of prophylaxis in haemophilia.
    Moreno MM; Cuesta-Barriuso R
    Blood Coagul Fibrinolysis; 2019 Mar; 30(2):55-57. PubMed ID: 30507712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prophylaxis in patients with haemophilia complicated by inhibitors].
    Paweł Ł
    Pol Merkur Lekarski; 2011 Mar; 30(177):211-4. PubMed ID: 21545000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacoeconomic impact of obesity in severe haemophilia children on clotting factor prophylaxis in a single institution.
    Majumdar S; Ostrenga A; Latzman RD; Payne C; Hunt Q; Morris A; Iyer R
    Haemophilia; 2011 Jul; 17(4):717-8. PubMed ID: 21323798
    [No Abstract]   [Full Text] [Related]  

  • 10. Ineffectiveness of prophylactic epsilon aminocaproic acid in severe hemophilia.
    STRAUSS HS; KEVY SV; DIAMOND LK
    N Engl J Med; 1965 Aug; 273(6):301-4. PubMed ID: 21417065
    [No Abstract]   [Full Text] [Related]  

  • 11. Current situation of regular replacement therapy (prophylaxis) for haemophilia in Japan.
    Taki M; Shirahata A
    Haemophilia; 2009 Jan; 15(1):78-82. PubMed ID: 18700841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and effectiveness of room temperature stable recombinant factor VIIa in patients with haemophilia A or B and inhibitors: Results of a multinational, prospective, observational study.
    Kavakli K; Demartis F; Karimi M; Eshghi P; Neme D; Chambost H; Sommer L; Zak M; Benson G
    Haemophilia; 2017 Jul; 23(4):575-582. PubMed ID: 28440004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term prophylaxis in severe haemophilia seems to preserve bone mineral density.
    Khawaji M; Akesson K; Berntorp E
    Haemophilia; 2009 Jan; 15(1):261-6. PubMed ID: 19149852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Objective quantification of adherence to prophylaxis in haemophilia patients aged 12 to 25years and its potential association with bleeding episodes.
    Pérez-Robles T; Romero-Garrido JA; Rodriguez-Merchan EC; Herrero-Ambrosio A
    Thromb Res; 2016 Jul; 143():22-7. PubMed ID: 27172834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current issues in prophylactic therapy for persons with hemophilia.
    Dunn AL; Abshire TC
    Acta Haematol; 2006; 115(3-4):162-71. PubMed ID: 16549891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between intracranial haemorrhage and prescribed prophylaxis in a large cohort of haemophilia patients in the United States.
    Witmer C; Presley R; Kulkarni R; Soucie JM; Manno CS; Raffini L
    Br J Haematol; 2011 Jan; 152(2):211-6. PubMed ID: 21114482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of recombinant activated factor VII (rFVIIa) in patients with congenital haemophilia with inhibitors: overall rFVIIa exposure and intervals following high (>240 μg kg⁻¹) rFVIIa doses across clinical trials and registries.
    Shapiro AD; Neufeld EJ; Blanchette V; Salaj P; Gut RZ; Cooper DL
    Haemophilia; 2014 Jan; 20(1):e23-31. PubMed ID: 24354484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orthopaedic evaluation in children with severe haemophilia A or B submitted to primary prophylaxis therapy in a coagulopathy treatment centre.
    De Podestá Haje D; Ono F; De Oliveira GB; Almeida J; De Paula JC; Batista Neto LV; Silva Barros SB
    Haemophilia; 2011 Mar; 17(2):228-32. PubMed ID: 21070500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of antibody to HIV in haemophiliacs in the United Kingdom: a second survey. AIDS Group of the United Kingdom Haemophilia Centre Directors with the co-operation of the United Kingdom Haemophilia Centre Directors.
    Clin Lab Haematol; 1988; 10(2):187-91. PubMed ID: 3262033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemophilia stress fractures--an increasing complication with better orthopaedic care.
    Carroll A; Nash MJ; Thachil J
    Haemophilia; 2013 May; 19(3):e178-80. PubMed ID: 23490261
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.